Peroxisome proliferator-activated receptor-α contributes to the anti-inflammatory activity of glucocorticoids

Molecular Pharmacology

Volumn 73, Issue 2, 2008, Pages 323-337

  Cuzzocrea, Salvatore ^a,b   Bruscoli, Stefano ^c   Mazzon, Emanuela ^a,b   Crisafulli, Concetta ^a   Donato, Valerio ^c   Di Paola, Rosanna ^a   Velardi, Enrico ^c   Esposito, Emanuela ^b,d   Nocentini, Giuseppe ^c   Riccardi, Carlo ^c  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; CLOFIBRATE; DEXAMETHASONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG POTENTIATION; ENZYME ACTIVATION; MACROPHAGE; MOUSE; NONHUMAN; PLEURISY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; GLUCOCORTICOIDS; MICE; MICE, KNOCKOUT; PLEURISY; PPAR ALPHA;

EID: 38749118317     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.041475     Document Type: Article

References (72)

1. Auphan N, DiDonato JA, Rosette C, Helmberg A, and Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286-290.
2. Ayroldi E, Zollo O, Bastianelli A, Marchetti C, Agostini M, Di Virgilio R, and Riccardi C (2007) GILZ mediates the antiproliferative activity of glucocorticoids by negative regulation of Ras signaling. J Clin Invest 117:1605-1615.
3. Baldwin AS Jr (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14:649-683.
4. Barlic J, Zhang Y, Foley JF, and Murphy PM (2006) Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferators-activated receptor gamma-dependent pathway. Circulation 114:807-819.
5. Barnes PJ (2006) Corticosteroid effects on cell signalling. Eur Respir J 27:413-426.
6. Barnes PJ and Karin M (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071.
7. Beg AA, Finco TS, Nantermet PV, and Baldwin AS Jr (1993) Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol Cell Biol 13:3301-3310.
8. Bernal-Mizrachi C, Weng S, Feng C, Finck BN, Knutsen RH, Leone TC, Coleman T, Mecham RP, Kelly DP, and Semenkovich CF (2003) Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice. Nat Med 9:1069-1075.
9. Bernal-Mizrachi C, Xiaozhong L, Yin L, Knutsen RH, Howard MJ, Arends JJ, Desantis P, Coleman T, and Semenkovich CF (2007) An afferent vagal nerve pathway links hepatic PPARalpha activation to glucocorticoid-induced insulin resistance and hypertension. Cell Metab 5:91-102.
10. Bianchini R, Nocentini G, Krausz LT, Fettucciari K, Coaccioli S, Ronchetti S, and Riccardi C (2006) Modulation of pro- and antiapoptotic molecules in double-positive (CD4CD8) thymocytes following dexamethasone treatment. J Pharmacol Exp Ther 319:887-897.
11. Bruscoli S, Di Virgilio R, Donato V, Velardi E, Baldoni M, Marchetti C, Migliorati G, and Riccardi C (2006) Genomic and non-genomic effects of different glucocorticoids on mouse thymocyte apoptosis. Eur J Pharmacol 529:63-70.
12. Buckingham JC, Loxley HD, Christian HC, and Philip JG (1996) Activation of the HPA axis by immune insults: roles and interactions of cytokines, eicosanoids, glucocorticoids. Pharmacol Biochem Behav 54:285-298.
13. Buss H, Dorrie A, Schmitz ML, Hoffmann E, Resch K, and Kracht M (2004) Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)-α, IKKβ-, IKKε, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J Biol Chem 279:55633-55643.
14. Cannarile L, Fallarino F, Agostini M, Cuzzocrea S, Mazzon E, Vacca C, Genovese T, Migliorati G, Ayroldi E, and Riccardi C (2006) Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokines. Blood 107:1039-1047.
15. Cassuto H, Kochan K, Chakravarty K, Cohen H, Blum B, Olswang Y, Hakimi P, Xu C, Massillon D, Hanson RW, et al. (2005) Glucocorticoids regulate transcription of the gene for phosphoenolpyruvate carboxykinase in the liver via an extended glucocorticoid regulatory unit. J Biol Chem 280:33873-33884.
16. Chikanza IC (2002) Mechanisms of corticosteroid resistance in rheumatoid arthritis: a putative role for the corticosteroid receptor beta isoform. Ann N Y Acad Sci 966:39-48.
17. Cifone MG, Migliorati G, Parroni R, Marchetti C, Millimaggi D, Santoni A, and Riccardi C (1999) Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. Blood 93:2282-2296.
18. Colville-Nash PR, Qureshi SS, Willis D, and Willoughby DA (1998) Inhibition of inducible nitric oxide synthase by peroxisome proliferator- activated receptor agonists: correlation with induction of heme oxygenase 1. J Immunol 161:978-984.
19. Cuzzocrea S, Bruscoli S, Crisafulli C, Mazzon E, Agostini M, Muia C, Esposito E, Di Virgilio R, Meli R, Vegeto E, et al. (2007) Estrogen receptor antagonist fulvestrant (ICI 182,780) inhibits the anti-inflammatory effect of glucocorticoids. Mol Pharmacol 71:132-144.
20. Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muia C, Centorrino T, and Caputi AP (2004) Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-alpha) in the development of inflammatory bowel disease in mice. Lab Investig 84:1643-1654.
21. Cuzzocrea S, Mazzon E, Di Paola R, Peli A, Bonato A, Britti D, Genovese T, Muia C, Crisafulli C, and Caputi AP (2006a) The role of the peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in the regulation of acute inflammation. J Leukoc Biol 79:999-1010.
22. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Ciccolo A, Centorrino T, De Sarro A, and Caputi AP (2001) Protective effects of N-acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat. FASEB J 15:1187-1200.
23. Cuzzocrea S, Nocentini G, Di Paola R, Agostini M, Mazzon E, Ronchetti S, Crisafulli C, Esposito E, Caputi AP, and Riccardi C (2006b) Proinflammatory role of glucocorticoid-induced TNF receptor-related gene in acute lung inflammation. J Immunol 177:631-641.
24. Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, Fruchart JC, Tedgui A, Haegeman G, and Staels B (1999) Peroxisome proliferator-activated receptor α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1. J Biol Chem 274:32048-32054.
25. Delerive P, Gervois P, Fruchart JC, and Staels B (2000) Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators. J Biol Chem 275:36703-36707.
26. Di Marco B, Massetti M, Bruscoli S, Macchiarulo A, Di Virgilio R, Velardi E, Donato V, Migliorati G, and Riccardi C (2007) Glucocorticoid-induced leucine zipper (GILZ)/NF-kappaB interaction: role of GILZ homo-dimerization and C-terminal domain. Nucleic Acids Res 35:517-528.
27. Diamond MI, Miner JN, Yoshinaga SK, and Yamamoto KR (1990) Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249:1266-1272.
28. Falkenstein E, Tillmann HC, Christ M, Feuring M, and Wehling M (2000) Multiple actions of steroid hormones-a focus on rapid, nongenomic effects. Pharmacol Rev 52:513-556.
29. Farrell RJ and Kelleher D (2003) Glucocorticoid resistance in inflammatory bowel disease. J Endocrinol 178:339-346.
30. Frankfurt O and Rosen ST (2004) Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates. Curr Opin Oncol 16:553-563.
31. Genovese T, Mazzon E, Di Paola R, Cannavo G, Muia C, Bramanti P, and Cuzzocrea S (2005) Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord trauma. Exp Neurol 194:267-278.
32. Gilroy DW, Lawrence T, Perretti M, and Rossi AG (2004) Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 3:401-416.
33. Hallahan DE and Virudachalam S (1997) Intercellular adhesion molecule 1 knockout abrogates radiation induced pulmonary inflammation. Proc Natl Acad Sci U S A 94:6432-6437.
34. Hoffman GS (1993) Immunosuppressive therapy for autoimmune diseases. Ann Allergy 70:263-274.
35. Kwak LW and Longo DL (1996) Lymphomas. Cancer Chemother Biol Response Modif 16:376-440.
36. Lemberger T, Staels B, Saladin R, Desvergne B, Auwerx J, and Wahli W (1994) Regulation of the peroxisome proliferator-activated receptor α gene by glucocorticoids. J Biol Chem 269:24527-24530.
37. Lépine S, Lakatos B, Courageot MP, Le Stunff H, Sulpice JC, and Giraud F (2004) Sphingosine contributes to glucocorticoid-induced apoptosis of thymocytes independently of the mitochondrial pathway. J Immunol 173:3783-3790.
38. Lösel R and Wehling M (2003) Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol 4:46-56.
39. Lovett-Racke AE, Hussain RZ, Northrop S, Choy J, Rocchini A, Matthes L, Chavis JA, Diab A, Drew PD, and Racke MK (2004) Peroxisome proliferator- activated receptor alpha agonists as therapy for autoimmune disease. J Immunol 172:5790-5798.
40. Luss H, DiSilvio M, Litton AL, Molina y Vedia L, Nussler AK, and Billiar TR (1994) Inhibition of nitric oxide synthesis enhances the expression of inducible nitric oxide synthase mRNA and protein in a model of chronic liver inflammation. Biochem Biophys Res Commun 204:635-640.
41. Marchetti MC, Di Marco B, Cifone G, Migliorati G, and Riccardi C (2003) Dexamethasone-induced apoptosis of thymocytes: role of glucocorticoid receptor-associated Src kinase and caspase-8 activation. Blood 101:585-593.
42. Meduri GU, Muthiah MP, Carratu P, Eltorky M, and Chrousos GP (2005) Nuclear factor-kappaB- and glucocorticoid receptor alpha- mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation 12:321-338.
43. Moraes LA, Piqueras L, and Bishop-Bailey D (2006) Peroxisome proliferator-activated receptors and inflammation. Pharmacol Ther 110:371-385.
44. Mullane KM, Kraemer R, and Smith B (1985) Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14:157-167.
45. Nantel F, Denis D, Gordon R, Northey A, Cirino M, Metters KM, and Chan CC (1999) Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation. Br J Pharmacol 128:853-859.
46. Neve BP, Corseaux D, Chinetti G, Zawadzki C, Fruchart JC, Duriez P, Staels B, and Jude B (2001) PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages. Circulation 103:207-212.
47. Nunoshiba T, DeRojas-Walker T, Wishnok JS, Tannenbaum SR, and Demple B (1993) Activation by nitric oxide of an oxidative-stress response that defends Escherichia coli against activated macrophages. Proc Natl Acad Sci U S A 90: 9993-9997.
48. Okamoto H, Iwamoto T, Kotake S, Momohara S, Yamanaka H, and Kamatani N (2005) Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis. Clin Exp Rheumatol 23:323-330.
49. Orii F, Ashida T, Nomura M, Maemoto A, Fujiki T, Ayabe T, Imai S, Saitoh Y, and Kohgo Y (2002) Quantitative analysis for human glucocorticoid receptor alpha/ beta mRNA in IBD. Biochem Biophys Res Commun 296:1286-1294.
50. Park LJ, Ju SM, Song HY, Lee JA, Yang MY, Kang YH, Kwon HJ, Kim TY, Choi SY, and Park J (2006) The enhanced monocyte adhesiveness after UVB exposure requires ROS and NF-kappaB signaling in human keratinocyte. J Biochem Mol Biol 39:618-625.
51. Ray A and Prefontaine KE (1994) Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc Natl Acad Sci U S A 91:752-756.
52. Rhen T and Cidlowski JA (2005) Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N Engl J Med 353:1711-1723.
53. Rossi A, Acquaviva AM, Iuliano F, Di Paola R, Cuzzocrea S, and Sautebin L (2005) Up-regulation of prostaglandin biosynthesis by leukotriene C4 in elicited mice peritoneal macrophages activated with lipopolysaccharide/ interferon-{gamma}. J Leukoc Biol 78:985-991.
54. Sakurai H, Suzuki S, Kawasaki N, Nakano H, Okazaki T, Chino A, Doi T, and Saiki I (2003) Tumor necrosis factor-α-induced IKK phosphorylation of NF-κB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J Biol Chem 278:36916-36923.
55. Salvemini D, Seibert K, Masferrer JL, Misko TP, Currie MG, and Needleman P (1994) Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Investig 93:1940-1947.
56. Salvemini D, Wang ZQ, Wyatt PS, Bourdon DM, Marino MH, Manning PT, and Currie MG (1996) Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br J Pharmacol 118:829-838.
57. Sands BE (2007) Inflammatory bowel disease: past, present, and future. J Gastroenterol 42:16-25.
58. Scheinman RI, Cogswell PC, Lofquist AK and Baldwin AS Jr (1995) Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270:283-286.
59. Schleimer RP (2000) Interactions between the hypothalamic-pituitary- adrenal axis and allergic inflammation. J Allergy Clin Immunol 106 (Suppl):S270-S274.
60. Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP, Delerive P, Fadel A, Chinetti G, Fruchart JC, et al. (1998) Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 393: 790-793.
61. Tomlinson A, Appleton I, Moore AR, Gilroy DW, Willis D, Mitchell JA, and Willoughby DA (1994) Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy. Br J Pharmacol 113:693-698.
62. Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, and Willoughby DA (1994) Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci U S A 91:2046-2050.
63. Viatour P, Merville MP, Bours V, and Chariot A (2005) Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 30:43-52.
64. Vlahos R and Stewart AG (1999) Interleukin-1alpha and tumour necrosis factoralpha modulate airway smooth muscle DNA synthesis by induction of cyclooxygenase-2: inhibition by dexamethasone and fluticasone propionate. Br J Pharmacol 126:1315-1324.
65. Warfel AH and Zucker-Franklin D (1986) Down-regulation of macrophage lysozyme by lipopolysaccharide and interferon. J Immunol 137:651-655.
66. Webster JI, Tonelli L, and Sternberg EM (2002) Neuroendocrine regulation of immunity. Annu Rev Immunol 20:125-163.
67. Weinberg JB, Misukonis MA, Shami PJ, Mason SN, Sauls DL, Dittman WA, Wood ER, Smith GK, McDonald B, Bachus KE, et al. (1995) Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 86:1184-1195.
68. Wikström AC (2003) Glucocorticoid action and novel mechanisms of steroid resistance: role of glucocorticoid receptor-interacting proteins for glucocorticoid responsiveness. J Endocrinol 178:331-337.
69. Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, McKee DD, Galardi CM, Plunket KD, Nolte RT, et al. (2002) Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature 415:813-817.
70. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, and Worley PF (1993) Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11:371-386.
71. Yamamoto Y and Gaynor RB (2001) Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 107:135-142.
72. Yang Q, Xie Y, Alexson SE, Nelson BD, and DePierre JW (2002) Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice. Biochem Pharmacol 63:1893-1900.